fidarestat has been researched along with Autoimmune Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ramana, KV; Shoeb, M; Srivastava, SK; Yadav, UC | 2 |
2 other study(ies) available for fidarestat and Autoimmune Disease
Article | Year |
---|---|
Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats.
Topics: Aldehyde Reductase; Animals; Aqueous Humor; Autoimmune Diseases; Cyclooxygenase 2; Cytokines; Dinoprostone; Disease Models, Animal; Enzyme Inhibitors; Eye Proteins; Fluorescent Antibody Technique, Indirect; Imidazolidines; Lymphocyte Activation; Male; Nitric Oxide Synthase Type II; Rats; Rats, Inbred Lew; Retinitis; Retinol-Binding Proteins; T-Lymphocytes; Uveitis | 2011 |
Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.
Topics: Adoptive Transfer; Aldehyde Reductase; Animals; Aqueous Humor; Autoimmune Diseases; Blotting, Western; Cells, Cultured; Chemokines; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Eye Proteins; Fluorescent Antibody Technique, Indirect; Imidazolidines; Leukocytes; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Reactive Oxygen Species; Retinol-Binding Proteins; T-Lymphocytes; Uveitis | 2011 |